P&T
Our
Other
Journal
MediMedia Managed Markets
Managed Care

 

 

January 2008

Geisinger’s “warranty” for CABG surgery has gotten a lot of attention, but is it transplantable?
Frank Diamond
Here are some of the challenges that health insurers face this year
Peter Kongstvedt, MD
We’ve made strides in increasing the transparency of pricing in the pharmacy supply chain, and now we need to change dispensing behavior
Thomas Kaye, RPh, MBA
Tougher standards being applied by insurers spur debate about what constitutes true value in a new drug
John Carroll
By assisting doctors, insurers can get all the payment that they are due, but that too often is lost
Marcia Naveh, MD
Mary V. Mason, MD, MBA ; Kara M. House, MBA ; Janice Linehan, PA-C, MHP ; Carol A. Speers, RN ; Lisa M. Joseph, RN, MBA



Departments
Editor's Memo
John A. Marcille
Viewpoint
As an idea, Geisinger’s ProvenCare program is a winner. What happens in the marketplace remains to be seen.
Michael L. Millenson
Medication Management
Although federal health agencies support the idea of having pharmacists administer vaccines to their patients, the roadblock continues to be a question of payment
Martin Sipkoff
Tomorrow's Medicine
Heart valves made from new composite materials minimize calcification, a common problem that can lead to a second valve replacement
Thomas Morrow, MD